-
PDL BioPharma Announces Retirement of $133.5M of 2.00% Convertible Senior Notes Due February 2012
Tuesday, July 5, 2011 - 7:01am | 52PDL BioPharma, Inc. (NASDAQ: PDLI) announced today that it has completed the retirement of the remaining $133.5 million in aggregate principal of the Company's 2.00% Convertible Senior Notes, due February 15, 2012, for $133.9 million plus interest of $1.0 million. With the completion of this...
-
Momentum Stocks For Next Week
Saturday, July 2, 2011 - 5:26pm | 2032( click to enlarge ) Motorola Mobility Holdings Inc (NYSE:MMI) has printed a bullish engulfing candlestick pattern on Friday. May be this is the right time to see a more significant rebound. Volume starts to pick up. Could make a huge move to the upside. Looks like we might bounce back into...
-
Sideline Money Flows In 07-01-2011
Friday, July 1, 2011 - 2:55pm | 997Cusick's Corner Buyers prevail. The sideline money is flowing into the market and it did it early on the heels of inline data this morning. The market is trending nicely, above the 50-Day Moving Average, taking back most of the pullback from the April highs, and this latest move is happening in...
-
Friday's Put/Call Ratio Leaders
Friday, July 1, 2011 - 12:44pm | 78Here are today's Put/Call Ratio leaders… 1. Pharmacyclics Inc. (NASDAQ: PCYC) 3,550 puts, 19 calls 2. Beazer Homes (NYSE: BZH) 5,000 puts, 100 calls 3. Carters Inc. (NYSE: CRI) 3,900 puts, 136 calls 4. Cadence Pharmaceuticals (NASDAQ: CADX) 5,704 puts, 204 calls 5. Titanium Metals Corp. (NYSE: TIE...
-
Biggest Winners and Losers as of 10:15AM
Friday, July 1, 2011 - 10:29am | 194Winners: Apollo Group (NASDAQ: APOL) is up over 8% after the company reported positive quarterly results on Thursday. Sina Corp (NASDAQ: SINA) is up almost 4% after the company turned down a $500M investment. Dendreon Corp (NASDAQ: DNDN) is up over 3% after it was revealed on Thursday that the...
-
Options Brief: Celsion Corporation
Friday, July 1, 2011 - 10:25am | 75Shares of Celsion Corporation (NASDAQ: CLSN) are lower on the session by 5.93%, trading at $3.17. Overall call volume is now running at 2.56x the daily average, with 8% of all calls traded being purchases on the offer. 3,087 contracts have traded on the session so far. Celsion Corporation is an...
-
Cyclacel Pharmaceuticals Announces Pricing of Underwritten Offering at $1.36/Share
Friday, July 1, 2011 - 9:15am | 200Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) today announced that it has priced an underwritten offering of an aggregate 7,617,646 units at an offering price of $1.36 per unit for gross proceeds of $10.36 million. Each unit consists of (i) one share of common stock and (ii) a...
-
StemCells Announces 1-10 Reverse Stock Split on July 6th
Friday, July 1, 2011 - 9:03am | 54StemCells, Inc. (Nasdaq: STEM) today announced that it will effect a one-for-ten reverse stock split at 12:01am on July 6, 2011. The Company anticipates that its common stock will begin trading on a split adjusted basis on The NASDAQ Global Market at the opening of trading on July 6, 2011.
-
Benzinga's Top Pre-Market NASDAQ Gainers
Friday, July 1, 2011 - 8:12am | 114Dendreon Corporation (NASDAQ: DNDN) shares advanced 4.59% to $41.25 in the pre-market session. Medicare agreed to pay for DNDN's prostate cancer therapy Provenge. Logitech International SA (NASDAQ: LOGI) shares advanced 1.96% to $11.46 in the pre-market session. LOGI is scheduled to report its Q1...
-
Celsion Corporation Announces $6.6 Million Registered Direct Offering
Friday, July 1, 2011 - 8:00am | 37Celsion Corporation (NASDAQ: CLSN) today announced that it has received commitments from institutional investors to purchase an aggregate of $6.6 million of the Company's securities in a registered direct offering.
-
A Peek Into The Market Before The Trading Starts
Friday, July 1, 2011 - 7:37am | 402Pre-open movers US stock futures are slightly higher this morning. Futures on the Dow Jones Industrial Average rose 22 points to 12,367.00 and futures on the S&P 500 stock index rose 0.30 point to 1,315.80. Nasdaq 100 futures gained 2.00 points to 2,323.00. A Peek Into Global Markets Asian...
-
Acorda Therapeutics Licenses Rights to Investigational Treatment for Spinal Cord Injury and Traumatic Brain Injury
Friday, July 1, 2011 - 7:01am | 176Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has licensed worldwide development and commercialization rights to a proprietary magnesium formulation from Medtronic, Inc. (NYSE: MDT), which will be referred to as AC105. Acorda plans to study AC105 as an acute treatment for...
-
Stocks to Watch for 07/1/11: Fresh 52 Week Highs and Lows
Friday, July 1, 2011 - 4:16am | 2869Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Thursday's trading session: 1) Walter Investment Company (NYSE: WAC): Shares of Walter Investment hit a 52-week...
-
UPDATE: Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE
Thursday, June 30, 2011 - 4:48pm | 345- FDA Approves Los Angeles Immunotherapy Manufacturing Facility, CMS Announces National Coverage Decision, and Product Specific Q-Code Effective - Dendreon Corporation (Nasdaq: DNDN) today announced significant milestones that support broad availability for on-label use of PROVENGE® (sipuleucel-T...
-
Rodman & Renshaw Reiterates Dendreon Market Outperform, $63 PT
Thursday, June 30, 2011 - 3:49pm | 95Rodman & Renshaw reiterated its Dendreon (NASDAQ: DNDN) Market Outperform rating and $63 price target in a research report published today. In the report, Rodman & Renshaw states, "Although near-term volatility is inevitable, we believe that long-term, the demand for Provenge will outstrip...